RecruitingPhase 3NCT03952299

Oxybutynin for Post-surgical Bladder Pain and Urgency

Sponsor

University of California, Davis

Enrollment

100 participants

Start Date

Sep 1, 2021

Study Type

INTERVENTIONAL

Conditions

Overactive Bladder Syndrome Neuropathic Bladder

Summary

Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.

Eligibility

Min Age: 4 YearsMax Age: 8 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Oral Oxybutynin and a drug called Oxybutynin Transdermal Patch for people with neuropathic bladder and overactive bladder syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Years to 8 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.